Tonix Pharmaceuticals files Form 3 for Chief Commercial Officer Thomas Englese
TNXP•Stock options disclosed
The disclosure also listed stock options covering 59,480 shares, with exercise prices ranging from $8.05 to $20.18.
Chief Commercial Officer files initial Form 3
Tonix Pharmaceuticals Chief Commercial Officer Thomas Englese filed an initial Form 3 for Tonix, reporting 694 shares held directly.
